"For genetics to truly go mainstream, patients and clinicians need automated workflow solutions like those Clear Genetics has created," said Sean George, co-founder and chief executive officer of ...

SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- Researchers from Invitae (OTC: NVTA), a leading medical genetics company, are showcasing their work next week at the 2024 American College of Medical ...

BURLINGTON, N.C. and SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae, a leading medical genetics company ...

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...

MORRISVILLE – Invitae will initiate a strategic realignment of its business operations along with implement cost reduction programs, including the layoffs of more than 1,000 employees, the company ...

— Expects to deliver approximately $326 million in non-GAAP annualized cost savings in 2023 — — Provides preliminary revenue and gross margin ranges for the second quarter of 2022; amends full-year ...

SEATTLE, July 22, 2021 /PRNewswire/ — Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed ...

BOSTON--(BUSINESS WIRE)--Outcomes4Me Inc., developer of a leading free mobile app and platform to navigate cancer treatment and care, today announced that it has partnered with Invitae Corporation ...

San Francisco-headquartered Invitae Corp NVTA defines itself as medical genetics company seeking to bring comprehensive genetic information into mainstream medicine, with the goal of improving ...

Vertex and Invitae grew revenue in the third quarter by 18% and 16.7%, respectively. Invitae's cash burn situation is a problem. The potential of Vertex's pipeline may not be fully priced in. Vertex ...